Risk of Venous Thromboembolism Recurrence Among Rivaroxaban Treated Patients Who Continued Versus Discontinued Therapy: Analyses Among VTE Patients

Alok A. Khorana; Jeffrey S Berger; Philip S Wells; Roger Seheult; Veronica Ashton; François Laliberté; Concetta Crivera; Dominique Lejeune; Jeff Schein; Peter Wildgoose; Patrick Lefebvre; Scott Kaatz

doi:10.1182/BLOOD.V128.22.144.144

Risk of Venous Thromboembolism Recurrence Among Rivaroxaban Treated Patients Who Continued Versus Discontinued Therapy: Analyses Among VTE Patients

Alok A. Khorana, Jeffrey S Berger, Philip S Wells, Roger Seheult, Veronica Ashton, François Laliberté, Concetta Crivera, Dominique Lejeune, Jeff Schein, Peter Wildgoose, Patrick Lefebvre, Scott Kaatz

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Blood
Volume	128
DOIs	https://doi.org/10.1182/BLOOD.V128.22.144.144
State	Published - Dec 2 2016

Disciplines

Internal Medicine
Medicine and Health Sciences

Access to Document

10.1182/BLOOD.V128.22.144.144License: Unspecified

OpenUrl availability

Full text

Cite this

Khorana, A. A., Berger, J. S., Wells, P. S., Seheult, R., Ashton, V., Laliberté, F., Crivera, C., Lejeune, D., Schein, J., Wildgoose, P., Lefebvre, P., & Kaatz, S. (2016). Risk of Venous Thromboembolism Recurrence Among Rivaroxaban Treated Patients Who Continued Versus Discontinued Therapy: Analyses Among VTE Patients. Blood, 128. https://doi.org/10.1182/BLOOD.V128.22.144.144

@article{dd9dbb694fb140249f2cc4a957e454d0,

title = "Risk of Venous Thromboembolism Recurrence Among Rivaroxaban Treated Patients Who Continued Versus Discontinued Therapy: Analyses Among VTE Patients",

author = "Khorana, {Alok A.} and Berger, {Jeffrey S} and Wells, {Philip S} and Roger Seheult and Veronica Ashton and Fran{\c c}ois Lalibert{\'e} and Concetta Crivera and Dominique Lejeune and Jeff Schein and Peter Wildgoose and Patrick Lefebvre and Scott Kaatz",

note = "Abstract. Background: The American College of Chest Physicians (ACCP) guidelines for venous thromboembolism (VTE) disease recommend treatment with anticoagulat",

year = "2016",

month = dec,

day = "2",

doi = "10.1182/BLOOD.V128.22.144.144",

language = "American English",

volume = "128",

journal = "Blood",

}

TY - JOUR

T1 - Risk of Venous Thromboembolism Recurrence Among Rivaroxaban Treated Patients Who Continued Versus Discontinued Therapy: Analyses Among VTE Patients

AU - Khorana, Alok A.

AU - Berger, Jeffrey S

AU - Wells, Philip S

AU - Seheult, Roger

AU - Ashton, Veronica

AU - Laliberté, François

AU - Crivera, Concetta

AU - Lejeune, Dominique

AU - Schein, Jeff

AU - Wildgoose, Peter

AU - Lefebvre, Patrick

AU - Kaatz, Scott

N1 - Abstract. Background: The American College of Chest Physicians (ACCP) guidelines for venous thromboembolism (VTE) disease recommend treatment with anticoagulat

PY - 2016/12/2

Y1 - 2016/12/2

UR - https://ashpublications.org/blood/article/128/22/144/91505/Risk-of-Venous-Thromboembolism-Recurrence-Among

U2 - 10.1182/BLOOD.V128.22.144.144

DO - 10.1182/BLOOD.V128.22.144.144

M3 - Article

VL - 128

JO - Blood

JF - Blood

ER -

Risk of Venous Thromboembolism Recurrence Among Rivaroxaban Treated Patients Who Continued Versus Discontinued Therapy: Analyses Among VTE Patients

Disciplines

Access to Document

OpenUrl availability

Other files and links

Cite this